We evaluated the prognostic significance of the C-reactive protein and alpha-fetoprotein in immunotherapy (CRAFITY) score, a composite index integrating C-reactive protein and alpha-fetoprotein, in HCC treated with ICIs. The gene discussed is AFP; the disease is hepatocellular carcinoma.